Citation Impact
Citing Papers
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
2009 Standout
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
2019 Standout
Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green
2018 StandoutNobel
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
2008
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Comprehensive molecular portraits of human breast tumours
2012 StandoutNature
Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment
2015
Breast cancer
2019 Standout
Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer
2007
Hallmarks of Cancer: The Next Generation
2011 Standout
Met Receptor Contributes to Trastuzumab Resistance of Her2-Overexpressing Breast Cancer Cells
2008
ErbB receptors and signaling pathways in cancer
2009
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
2018 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Differences in Risk Factors for Local and Distant Recurrence After Breast-Conserving Therapy or Mastectomy for Stage I and II Breast Cancer: Pooled Results of Two Large European Randomized Trials
2001
A view on drug resistance in cancer
2019 StandoutNature
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
2009 Standout
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Paclitaxel poliglumex for ovarian cancer
2011
Roles of Fas and Fas ligand during mammary gland remodeling
2000
Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2)
2010
Catalysis for fluorination and trifluoromethylation
2011 StandoutNature
Breast-conserving therapy as a model for creating new knowledge in clinical oncology
1996
1998–1999 Patterns of Care Study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of Stage I-II breast cancer
2005
Bilateral Mastectomy versus Breast-Conserving Surgery for Early-Stage Breast Cancer
2015
The Evolving Landscape of Brain Metastasis
2018
Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium
2020
Postmastectomy radiotherapy in the management of operable breast cancer
1994
The use of combinations of monoclonal antibodies in clinical oncology
2015
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
A Good Drug Made Better: The Fulvestrant Dose-Response Story
2014
Chronic Health Conditions in Adult Survivors of Childhood Cancer
2006 Standout
Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
2010 Standout
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy
2009
Treatment for the endocrine resistant breast cancer: Current options and future perspectives
2017
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
2011 Standout
Valvular Dysfunction and Carotid, Subclavian, and Coronary Artery Disease in Survivors of Hodgkin Lymphoma Treated With Radiation Therapy
2003
Radiotherapy after Breast-Preserving Surgery in Women with Localized Cancer of the Breast
1993
Receipt of locoregional therapy among young women with breast cancer
2012
Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy
1997 Standout
Pancreatic Cancer
2010 Standout
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Lymphangiogenesis and lymphatic metastasis in breast cancer
2009
The TNF and TNF Receptor Superfamilies
2001 Standout
Treatment of Breast Cancer
1998
Twice-daily, split-course abdominopelvic radiation therapy after chemotherapy and positive second-look laparotomy for epithelial ovarian carcinoma
1991
Fulvestrant is an effective and well-tolerated endocrine therapy for postmenopausal women with advanced breast cancer: results from clinical trials
2004
Second Malignant Neoplasms in Five-Year Survivors of Childhood Cancer: Childhood Cancer Survivor Study
2001
Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer
2014
Insulin-Like Growth Factor 1 Receptor Targeted Therapeutics: Novel Compounds and Novel Treatment Strategies for Cancer Medicine
2008
The Association of Surgical Margins and Local Recurrence in Women with Early-Stage Invasive Breast Cancer Treated with Breast-Conserving Therapy: A Meta-Analysis
2014
Late effects of childhood cancer therapy
2002
Overall survival according to type of surgery in young (≤40 years) early breast cancer patients: A systematic meta-analysis comparing breast-conserving surgery versus mastectomy
2015
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
Cancer of the Ovary
2004 Standout
Coated pits, coated vesicles, and receptor-mediated endocytosis
1979 StandoutNatureNobel
Fluorine in medicinal chemistry
2007 Standout
SuFEx Click Chemistry Enabled Late-Stage Drug Functionalization
2018 StandoutNobel
Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes.
1983
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Fulvestrant (Faslodex®)—How to Make a Good Drug Better
2007
Trastuzumab in the management of early and advanced stage breast cancer.
2007
The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide ofStreptococcus pneumoniaein the marginal zone of mouse spleen
2003 StandoutNobel
Mammalian reticulocytes lose adhesion to fibronectin during maturation to erythrocytes.
1985 StandoutNobel
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Member‐associated changes during erythropoiesis. On the mechanism of maturation of reticulocytes to erythrocytes
1981
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Nationwide Trends in Mastectomy for Early-Stage Breast Cancer
2014
Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: Selective externalization of the receptor
1983 Standout
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease
2003
The asialoglycoprotein receptor internalizes and recycles independently of the transferrin and insulin receptors
1983 StandoutNobel
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Cancer, Clinical Pharmacology, and Aging
1987
Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
2016
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells.
1983
NCCN Task Force Report: Adjuvant Therapy for Breast Cancer
2006
Contralateral prophylactic mastectomy in breast cancer: what to discuss with patients
2020
Fluorine in medicinal chemistry: A review of anti-cancer agents
2006
Visible Light Photoredox Catalysis with Transition Metal Complexes: Applications in Organic Synthesis
2013 Standout
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a Diagnosis of Invasive Unilateral Early-Stage Breast Cancer in the United States, 2004-2012
2017
Transferrin and Iron Uptake by Rabbit Bone Marrow Cells in Vitro
1974
Does Locoregional Radiation Therapy Improve Survival in Breast Cancer? A Meta-Analysis
2000
Tumors: Wounds That Do Not Heal
1986 Standout
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
2015
A Randomized Phase II Study of Veliparib with Temozolomide Or Carboplatin/Paclitaxel Versus Placebo with Carboplatin/Paclitaxel in Brca1 / 2 Metastatic Breast Cancer: Design and Rationale
2016
Standards for breast-conservation treatment
1992
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Fertility preservation before breast cancer treatment appears unlikely to affect disease‐free survival at a median follow‐up of 43 months after fertility‐preservation consultation
2019
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
2005 Standout
Surgery of the Spleen
1983
American Joint Committee on Cancer Prognostic Factors Consensus Conference
1999
Biologically active low density lipoprotein in human peripheral lymph.
1978 StandoutNobel
Works of Steven E. Come being referenced
BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer
2016
Chemotherapy and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2–Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
2014
Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer
2015
Phase II Trial of Lapatinib for Brain Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
2008
Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer
2011
A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancer
2013
Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer
2007
Pharmacokinetic Profile of Intramuscular Fulvestrant in Advanced Breast Cancer
2004
Cosmetic results after surgery, chemotherapy, and radiation therapy for early breast cancer
1991
Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome.
1991
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma
2005
Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactions
2007
The Sequencing of Chemotherapy and Radiation Therapy after Conservative Surgery for Early-Stage Breast Cancer
1996
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women
2003
Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure
1989
Long-term results of post-operative radiation therapy following mastectomy with or without chemotherapy in stage I–III breast cancer
1993
A prospective study of concurrent cyclophosphamide/methotrexate/5‐fluorouracil and reduced‐dose radiotherapy in patients with early‐stage breast carcinoma
2004
Endocrine treatment options for advanced breast cancer – the role of fulvestrant
2004
Conservative surgery and radiotherapy for early breast cancer
1990
Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma
1998
The effect of adjuvant chemotherapy on the cosmetic results after primary radiation treatment for early stage breast cancer
1984
Presentation of breast cancer in young women
2009
Primary radiation therapy for locally advanced breast cancer
1987
Association of Breast Cancer Surgery With Quality of Life and Psychosocial Well-being in Young Breast Cancer Survivors
2020
TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer
2015
Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome
1996
Surface Remodeling vs. Whole-Cell Hemolysis of Reticulocytes Produced With Erythroid Stimulation or Iron Deficiency Anemia
1974
Current status of conservative surgery and radiotherapy as primary local treatment for early carcinoma of the breast
1985
Surface Remodelling of Reticulocytes produced in Response to Erythroid Stress
1972
Sequencing of Chemotherapy and Radiation Therapy in Early-Stage Breast Cancer: Updated Results of a Prospective Randomized Trial
2005
Body image in recently diagnosed young women with early breast cancer
2012
Sequential multi-agent chemotherapy and whole abdominalirradiation for stage III ovarian carcinoma
1986
Perceptions, Knowledge, and Satisfaction With Contralateral Prophylactic Mastectomy Among Young Women With Breast Cancer
2013
A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil.
1978
Staging in non-Hodgkin's lymphoma: Approach, results and relationship to histopathology
1979
Phase II trial of lapatinib for brain metastases in patients with HER2+ breast cancer
2006
Tolerability and efficacy of 500 mg fulvestrant in postmenopausal women with estrogen receptor (ER)+ advanced breast cancer
2009
Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
2006
Issues of controversy in radiation therapy and combined modality approaches to Hodgkin's disease
1979